Member Info for Computer909

@Harley64: We still had the Visitect antibody test and ELISA shambles, that netted zero sales.

Are we in a stronger position, having received loan equipment from the DHSC?, we all wait to find out, My fear is that the company has outgrown the BOD, particularly the commercial side seems to be heavily lacking and that underpins the whole company.

If you look at the working capital estimate from the placing last year of £2.3M then that only goes so far, especially with the reported headcount increase form 135 at that time to 250+ now. It is more important now than ever to get some revenue streams active, but once again we seem to be sat on our hands.

@sledgey121: You don't have a clue as to how much I or anyone else has invested in here, I suspect a little more than yourself though, Clearly you would be more than happy for CK to make the same mess of 2021 as he did for 2020.

It always comes down to numbers in the end, and in 2020 this world leading diagnostics company that was perfectly poised to exploit the opportunities covid was presenting (or at least thats what they told us when they asked for a few bob in the placing) makes a loss, and is in danger of repeating the same mistakes again. I still wait for Tech Transfer news, the commercialisation of the test (4 months late) and news that the DHSC arent going to shaft us again.

"So you think it takes 250+ staff 1 minth to make a handful of tests,"

We would have hoped that 250+ staff could have got Tech Transfer complete by now!

We all have to agree is something doesn't add up, We are a test manufacturer that makes test to order, we havent had any large scale orders as yet, and ODX/Walbrook have stated many times they would release to the market any orders of interest, So what exactly are the 250 staff doing? , Perhaps they are all playing Jenga, there should be plenty of bricks about !

@Trickymatters: “ They downed tools to switch focus to help out in the pandemic”

Exactly how have they helped out? , name one thing ODX have done up to now that has made a difference in the response to covid?

@Bedhead: “sure they’ll all be on a bonus (& share related) this year!”

I bet they are hoping any bonus isn't sales related

@upomega, “maybe a good question to put to the company”, perhaps a more appropriate one would be what Jag Grewal been doing all year?

Jag is responsible for the commercial strategy and development of the Group driven through sales and marketing

That doesn't seem to be going very well

@Lovejoy22: Exactly

@MIKODX, been hear since may last year , patiently waiting as you say, thats all we get from ODX, if i end up selling at a loss there are a lot more on here that will be underwater from the averages i have seen posted here recently

@Eazy, I’m hoping that even he cant screw up many more times, i have my sell price set, i was hoping we would get there with the tech transfer, but if it takes much longer i’ll need to adjust for inflation!

And there it is again..... the NDA

Walbrook have confirmed many times there is no NDA in place, when there is any news they will release it

@Eazy: How much rope will you give Colin, we have gone nearly a year since we gave him £11m to spend on exploiting the Covid opportunities , and exactly what has he achieved with it?

“No wonder omega is confident they can fill capacity for quite some time yet”

Would be nice if they could be confident of making a few sales!

Omega “Buy the dip” Diagnostics !

“Don't forget Colin had an extended break at xmas aswell”

And it turned out they were doing sod all then as well, 20th week of Tech Transfer this week, God I hope the Mologic test is selected by the DHSC, otherwise it will be the fourth wave before we get a test out of the door

@Trickymatters

From Walbrook

“Omega are not involved in the performance evaluations process and they are currently waiting to hear which test / tests have passed. There has been no guidance from the DHSC on how long this process with take. Given Omega is not involved in the process it is not able to give and update on the process and I would expect shareholders to be updated when Omega is informed which test it is to produce”

The only manipulation we can clearly point to is the pump via twitter before the directors sold

“April is where Colin has alluded to us producing now 2m per week- let’s hope we get some great news this week after his well deserved holiday”

Omega stated they would be “delivering” 2M tests per week in april, we wait to see if they were telling the truth, or actually ramping the price for the directors to get a good price,

“Did CK speculate about roll out end of april?“

Depends if you mean ramping twitter Colin or his deramping RNS alter ego

1billion tests supplied by innova by mid april, no wonder the idiot government are in no hurry to find a sovereign test for us to manufacture

@SurreyLad, the Chembio test is unique in that it differentiates covid and flu, but is only approved for Lab use

https://chembio.com/investors/press-releases/
https://seekingalpha.com/news/3679182-chembio-launches-point-of-care-test-to-differentiate-covid-19-and-flu

Although there are many competitors in the market for our test this isn’t one